Why Amazon's Whole Foods Deal Is Slamming Pharma Stocks

Why Amazon's Whole Foods Deal Is Slamming Pharma Stocks
AP Photo/Richard Drew, File

The drug industry really doesn't want to compete with Amazon.

News that Amazon is buying health-focused grocery chain Whole Foods shook the business world Friday. The $13.7 billion deal has, predictably, been a veritable albatross round the necks of Kroger, Costco, and other large supermarkets and retailers. But the proposed buyout is also taking a toll on some of the biggest pharmacy chains and drug distributors in America.



Comment
Show comments Hide Comments


Related Articles